Uso del antígeno prostático específico (PSA) para el cribado de cáncer de próstata en la población de 70 años o más de una zona de salud urbana, 2018-2020. Un estudio transversal
- DOI
- 10.1016/j.semerg.2022.101876
- Published
- 2023-01
- Container
- Medicina de Familia. SEMERGEN
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.semerg.2022.101876,
title = {Uso del antígeno prostático específico (PSA) para el cribado de cáncer de próstata en la población de 70 años o más de una zona de salud urbana, 2018-2020. Un estudio transversal},
author = {A. Urquijo-Moraza and J. Guinea-Castañares and J.M. Iturralde-Iriso},
year = {2023},
journal = {Medicina de Familia. SEMERGEN},
doi = {10.1016/j.semerg.2022.101876},
url = {https://doi.org/10.1016/j.semerg.2022.101876}
}RIS
TY - JOUR TI - Uso del antígeno prostático específico (PSA) para el cribado de cáncer de próstata en la población de 70 años o más de una zona de salud urbana, 2018-2020. Un estudio transversal AU - A. Urquijo-Moraza AU - J. Guinea-Castañares AU - J.M. Iturralde-Iriso PY - 2023 JO - Medicina de Familia. SEMERGEN DO - 10.1016/j.semerg.2022.101876 UR - https://doi.org/10.1016/j.semerg.2022.101876 ER -
APA
Urquijo-Moraza, A., Guinea-Castañares, J., & Iturralde-Iriso, J. (2023). Uso del antígeno prostático específico (PSA) para el cribado de cáncer de próstata en la población de 70 años o más de una zona de salud urbana, 2018-2020. Un estudio transversal. Medicina de Familia. SEMERGEN. https://doi.org/10.1016/j.semerg.2022.101876
Source records
- crossref · retrieved 2026-09-26T22:12:43.275Z